Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 18, Issue 6, 2000, Pages 1346-1350

  Miller, Vincent A ^a   Krug, Lee M ^a   Ng, Kenneth K ^a   Pizzo, Barbara ^a   Perez, Wendy ^a   Heelan, Robert T ^a   Kris, Mark G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CORTICOSTEROID; DOCETAXEL; NAVELBINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0034062813     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.6.1346     Document Type: Article

References (22)

1. Haldar S, Basu A, Croce C: Bcl2 is the guardian of microtubule integrity. Cancer Res 57:229-233, 1997
2. Miller VA, Ng K, Grant SC, et al: New chemotherapeutic agents in NSCLC, in Roth JA, Cox JD, Hong WK (eds): Lung Cancer (ed 2). Maiden, MA, Blackwell Science, Inc. 1998, pp 217-234
3. Miller VA, Kris MG: Vinorelbine for the treatment of advanced non-small cell lung cancer. Med Lett Drugs Ther 37:72-73, 1995
4. Bissery MC, Vrignaud P, Bayssas M, et al: Preclinical in vivo activity of docetaxel-containing combinations. Proc Am Soc Clin Oncol 14:489, 1995 (abstr 1599)
5. Aoe K, Ueoka H, Kiura K, et al: Synergistic effect of docetaxel (DCT) and vinorelbine (VNB) against in vitro growth of a human small-cell lung cancer cell line. Proc Am Assoc Cancer Res 37:375, 1996 (abstr 2560)
6. Knick V, Eberwein D, Miller CG: Vinorelbine tartrate and paclitaxel combinations: Enhanced activity against in vivo P388 murine leukemia cells. J Natl Cancer Inst 87:1072-1077, 1995
7. Botta M, Arboscello E, Lerza R, et al: Effects of docetaxel on the in vitro growth of human myeloid progenitors. Anticancer Res 19: 1855-1858, 1999
8. Aoe K, Kiura K, Ueoka H, et al: Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines. Anticancer Res 19:291-300, 1999
9. Miller V, Grant S, Ng K, et al: Phase I trial of docetaxel (DTX) and vinorelbine (VNR) with filgrastim in patients with advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 17:471a, 1998, (abstr 1813)
10. Kris MG, Gralla RJ, Kalman LA, et al: Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment. Cancer Treat Rep 69:387-395, 1985
11. Eagan RT, Fleming TR, Schoonover V: Evaluation of response criteria in advanced lung cancer. Cancer 44:1125-1128, 1979
12. Jett JR, Su JQ, Krook JE, et al: Measurable or assessable disease in lung cancer trials: Does it matter? J Clin Oncol 12:2677-2681, 1994
13. Fleming TR: One-sample multiple testing procedure for phase II clinical trials. Biometrics 38:143-151, 1982
14. 2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer. Cancer 75:968-972, 1995
15. Vander Els NJ, Miller V: Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy. Chest 114:1779-1781, 1998
16. Ramanathan RK, Belani CP, Reddy VV: Transient pulmonary infiltrates: A hypersensitivity reaction to paclitaxel. Ann Intern Med 124:278, 1996 (letter)
17. Monnier A, Riviere A, Douillard JY, et al: Phase II study of docetaxel (Taxotere) and vinorelbine in chemotherapy naive patients with advanced non-small-cell lung carcinoma (NSCLC). Proc Am Soc Clin Oncol. 15:378, 1996 (abstr 1129)
18. Kourousis C, Androulakis N, Kakolyris S, et al: First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine. Cancer 83:2083-2090, 1998
19. Blagosklonny MV, Schulte T, Nguyen P, et al: Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 56:1851-1854, 1996
20. Klaubner N, Parangi S, Flynn E, et al: Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57:81-86, 1997
21. Strobel T, Kraeft S-K, Chen LB, et al: BAX expression is associated with enhanced intracellular accumulation of paclitaxel: A novel role for BAX during chemotherapy-induced cell death. Cancer Res 58:4776-4781, 1998
22. Kris M, Gralla R, Wertheim M, et al: Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. Cancer Treat Rep 70:1091-1096, 1986